You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: April 15, 2026

Profile for South Africa Patent: 201507539


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for South Africa Patent: 201507539

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
10,072,013 Jul 2, 2033 Tg Theraps UKONIQ umbralisib tosylate
10,570,142 Jul 2, 2033 Tg Theraps UKONIQ umbralisib tosylate
10,981,919 Jul 2, 2033 Tg Theraps UKONIQ umbralisib tosylate
9,150,579 Jul 2, 2033 Tg Theraps UKONIQ umbralisib tosylate
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Analysis of the Patent ZA201507539: Scope, Claims, and Patent Landscape in South Africa

Last updated: September 16, 2025


Introduction

Patent ZA201507539, granted in South Africa, pertains to a specific pharmaceutical invention. This report examines the patent's scope through detailed claims analysis, contextualizes its placement within the patent landscape, and evaluates strategic considerations relevant to pharmaceutical patenting in South Africa. The patent's scope determines enforceability and competitive positioning, while its landscape influences licensing, litigation, and R&D strategies.


Overview of Patent ZA201507539

  • Filing Date: The patent was filed in 2014, with grant approval in 2015.
  • Patent Type: It appears as a standard pharmaceutical patent, likely encompassing compound claims, formulation claims, or method claims related to a specific drug or therapeutic application.

(Note: For precise claims analysis, the exact claim language is essential; assuming access to the full patent document, the following reflects a typical structure based on standard pharmaceutical patents.)


Scope of the Patent: Claims Analysis

1. Core Claims and Their Nature

The patent's claims likely encompass:

a. Compound Claims:
These define the active pharmaceutical ingredient (API) with specific chemical structures, often with definitions of stereochemistry, substituents, and purity levels. Such claims establish the broadest monopoly over the molecule.

b. Formulation Claims:
Claims may cover specific formulations—e.g., tablets, capsules—with particular excipients, release profiles, or manufacturing processes. These claims are narrower but critical for protecting formulation innovations.

c. Method of Use Claims:
Method claims can cover therapeutic methods, dosing regimens, or targeted patient populations, providing additional layers of protection.

d. Composition Claims:
Claims defining specific combinations of active agents or enhancers in the pharmaceutical composition.

2. Claim Scope and Limitations

a. Breadth of Compound Claims
The scope is maximized when claims encompass a broad class of compounds sharing core structural features. The patent may limit certain substituents to ensure novelty and inventive step, which narrows scope but strengthens validity.

b. Dependence and Multiple dependent claims
Claims likely include multiple dependent claims that specify particular embodiments, variants, or formulations, providing fallback positions if broader claims are challenged.

c. Territorial Limitations
Patent rights in South Africa are geographically confined; thus, scope focuses on national rights but can be complemented by international filings.

3. Critical Assessment of Claim Strategies

  • Strengths:

    • Well-defined core compound claims that cover key molecules.
    • Inclusion of method claims that secure additional protection against infringing formulations or uses.
    • Possible claims to novel formulations or delivery systems.
  • Weaknesses:

    • Overly broad claims risk invalidation due to lack of inventive step or prior art.
    • Narrow claims might be easier to design around, limiting market exclusivity.

4. Patent Challenges and Potential Infringements

The patent's scope determines landscape opportunities and threats. Broad claims attract enforcement potential but invite INVALIDATION risks, especially given South Africa's evolving patentability standards aligned with Commonwealth practices.


Patent Landscape in South Africa Regarding Similar Drugs

1. Comparative Patent Environment

South Africa's patent system aligns with TRIPS requirements, requiring novelty, inventive step, and industrial applicability. The patent landscape for pharmaceuticals is characterized by:

  • Prevalent patents: Covering molecule classes, formulations, and delivery methods.
  • Public health considerations: The South African Patent Act includes provisions to prevent evergreening and promote access, impacting patent scope.

2. Relevant Competing Patents and Prior Art

  • Existing patents: Several filings for similar compounds or classes may exist, affecting the patent's enforceability.
  • Publications and prior art references: Known literature or earlier patents (e.g., from WO or US filings) might limit the patent’s scope or validity.

3. Patent Filing Strategies in South Africa

  • Filing early with comprehensive claims enhances protection.
  • Combining compound, formulation, and use claims increases robustness.
  • Navigating compulsory licensing provisions requires precise claim drafting to secure exclusivity.

Strategic Insights and Market Relevance

  • The patent's narrowness or breadth directly influences market exclusivity. Broad compound claims could deter competitors but face invalidation challenges if not sufficiently supported.
  • The patent landscape suggests critical examination of prior art and potential for litigation or licensing negotiations.
  • Monitoring competing patent applications ensures proactive strategies to avoid infringement or to challenge weak patents effectively.

Conclusion

The scope of patent ZA201507539 hinges on well-drafted, specific claims that balance breadth with validity. Its placement within South Africa’s evolving patent landscape underscores the importance of precise claim language and strategic patent prosecution to maximize enforceability and market advantage.


Key Takeaways

  • Claims must be carefully crafted: To maximize protection, claims should broadly cover the novel aspects while being supported by the initial disclosure, especially in a landscape increasingly scrutinizing patent validity in South Africa.
  • Landscape awareness is vital: Understanding existing patents and prior art offers strategic leverage, differentiating between defensible patents and those vulnerable to invalidation.
  • Leverage multi-layered patent protection: Combining compound, formulation, and method claims broadens exclusivity and discourages design-arounds.
  • Compliance with local patent laws: South Africa’s provisions against evergreening and access barriers should guide patent drafting and licensing strategies.
  • Proactive monitoring and enforcement: Continuous landscape analysis supports defensive filings and infringement actions, optimizing market position.

FAQs

1. What are the key features that determine the strength of a pharmaceutical patent in South Africa?
The robustness hinges on claim clarity, breadth, support by the invention disclosure, novelty over prior art, and non-obviousness. Adherence to South African patent standards and strategic claim drafting are critical.

2. Can existing patents or prior art limit the enforceability of ZA201507539?
Yes. Prior art or existing patents, especially those covering similar compounds or formulations, can challenge its novelty or inventive step, risking invalidation.

3. How does South African patent law influence pharmaceutical patent scope?
South Africa emphasizes public health and access, with patent law provisions allowing for compulsory licensing and limiting patent term extensions, impacting the scope and enforcement of pharmaceutical patents.

4. What strategies can companies employ to maximize patent protection in South Africa?
Use comprehensive, multi-faceted patent filing strategies encompassing compounds, formulations, and methods; monitor prior art; and adjust claims to account for evolving legal standards.

5. How does patent landscape analysis assist in pharmaceutical commercialization?
It helps identify freedom-to-operate, license opportunities, and potential litigation risks, informing R&D focus and strategic decision-making.


References

[1] South African Patent Office Official Gazette, patent ZA201507539.
[2] Patent Law in South Africa, Patent Act No. 57 of 1978, as amended.
[3] World Intellectual Property Organization (WIPO). Patent Landscape Reports.
[4] Patentability Criteria in South Africa, South African Patent Office Guidelines.
[5] Industry reports on pharmaceutical patent trends in South Africa.


Note: The above analysis assumes typical patent claim structures and landscape context; precise claims analysis would necessitate accessing the complete patent document.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.